← Leaderboards
Renee Christopher
Novasterilis, Inc.
$1,671,893
Attributed
$1,671,893
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $882.3K · FY2006–08$1M$750K$500K$250K$0
'06
'07
'08
Funding mix
By agency
NIH$1,671,893 · 2
By mechanism
R44$1,671,893 · 2
Top collaborators
No co-investigators on record.
Most similar at Novasterilis, Inc.
Same institution · by research overlap
- Julien Fey$1,996,031
- Penny T Starkey$95,173
- Timothy W Christensen$415,246
- David C Burns$100,000
- Ankita Sarkar$892,763
Others in their field
Top investigators on “Sterilization For Infection Control”
- Dario Aa Vignali · University Of Pittsburgh At Pittsburgh$26,982,359
- Thomas William Geisbert · Boston University Medical Campus$26,279,541
- John M. Sedivy · Brown University$12,925,113
- Keri, Hammel · The Emmes Company, Llc$11,064,901
- Nancy Logan Haigwood · University Of Washington$11,041,123
- Katerina Heran Darwin · New York University School Of Medicine$10,476,460
Research focus
Sterilization For Infection ControlVirus InactivationMonitorSterilityTechnologyVirusFundingMedical DeviceMusculoskeletalSocietiesSurgeonCarbon DioxideTissue BanksCollaborationsAllograftingCommercializationAdoptedConditionBiomechanicsCostAmericanOrthopedicsImplantAffect
Grant awards (4)
Terminal Sterilization of Tendon Allografts Using Supercritical CO2- Phase II$314,460
R44 · FY2008 · AR · contact PI
A Novel Method for Reduction of Bioburden in Bone Allografts - Phase II$441,762
R44 · FY2007 · AR · contact PI
Terminal Sterilization of Tendon Allografts Using Supercritical CO2- Phase II$440,580
R44 · FY2007 · AR · contact PI
A Novel Method for Reduction of Bioburden in Bone Allografts - Phase II$475,091
R44 · FY2006 · AR · contact PI